1AD 4.00% 2.4¢ adalta limited

Ann: AD-214 pathway to IPF efficacy studies, page-57

  1. 2,889 Posts.
    lightbulb Created with Sketch. 241
    ? Efficacy data is due early 2022. Why is everyone posting like the sky is calling in here. I really hope people are doing their own research and not selling based on the hyperbole posted on here over theist day or so.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.